ロード中...
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
BACKGROUND: The clinical impact of neutralizing antibodies against interferon-beta (NAb) is controversial. Their presence can lead to a decrease in interferon-beta (IFNβ) efficacy. Fatigue reported in patients with multiple sclerosis (MS) may be associated with an unfavorable clinical course. We con...
保存先:
| 出版年: | BMC Neurol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4256902/ https://ncbi.nlm.nih.gov/pubmed/25433670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0215-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|